Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Indian Pediatrics

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13312-014-0445-5PMID 25031133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subcommittee on Attention-Deficit/Hyperactivity Disorder

  2016cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

  2012cited by this paper
• A preliminary study of factors affecting adherence to medication in clinic children with attention-deficit/hyperactivity disorder

  2011cited by this paper
• Atomoxetine and Methylphenidate Treatment in Children with ADHD: The Efficacy, Tolerability and Effects on Executive Functions

  2011cited by this paper
• Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

  2011cited by this paper
• ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

  2011cited by this paper
• Work Group on Quality Issues

  2010cited by this paper
• Psychopharmacology of ADHD in pediatrics: current advances and issues

  2009cited by this paper
• The Declaration of Helsinki and public health.

  2008cited by this paper
• Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

  2008cited by this paper
• Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.

  2007cited by this paper
• Atomoxetine versus Methylphenidate in Paediatric Outpatients with Attention Deficit Hyperactivity Disorder: A Randomized, Double-Blind Comparison Trial

  2007cited by this paper
• The clinical global impressions scale: applying a research tool in clinical practice.

  2007influential reference
• A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD)*

  2007cited by this paper
• Effects of atomoxetine and methylphenidate on sleep in children with ADHD.

  2006cited by this paper
• Outcomes of OROS® methylphenidate compared with atomoxetine in children with ADHD: A multicenter, randomized prospective study

  2005cited by this paper
• Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population.

  2003influential reference
• The worldwide prevalence of ADHD: is it an American condition?

  2003cited by this paper
• Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

  2002cited by this paper
• Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management.

  2000cited by this paper
• [Children with ADHD].

  1999cited by this paper
• Adult psychiatric status of hyperactive boys grown up.

  1998cited by this paper
• Obtaining Systematic Teacher Reports of Disruptive Behavior Disorders Utilizing DSM-IV

  1998cited by this paper
• Diagnostic and Statistical Manual of Mental Disorder

  1980cited by this paper

• Efficacy and safety of atomoxetine in the treatment of ADHD in children and adolescents: a systematic review

  2026cites this paper
• Personalization of pharmacological treatments for ADHD: Why it is advisable and possible options to achieve it.

  2022cites this paper
• The effects of stimulant and non-stimulant medications on the autonomic nervous system (ANS) functioning in people with ADHD: A systematic review and meta-analysis

  2022influential citation
• A systematic review of evidence-based interventions for child and adolescent mental health problems in low- and middle-income countries.

  2022cites this paper
• Treatments for child and adolescent attention deficit hyperactivity disorder in low and middle-income countries: A narrative review.

  2022cites this paper
• Can EEG Predict Response to Atomoxetine in attention deficit hyperactivity disorder at 1 Week?

  2021cites this paper
• ADHD: Reviewing the Causes and Evaluating Solutions

  2021cites this paper
• Central nervous system stimulants and drugs that suppress appetite

  2020cites this paper
• A META-ANALYSIS OF PHARMACOLOGICAL AND ALLIED THERAPY IN CHILDREN WITH ADHD

  2020cites this paper
• Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder: a systematic review

  2019cites this paper
• Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

  2018cites this paper
• Cardiovascular effects of methylphenidate in children with attention deficit hyperactivity disorder (ADHD)

  2018cites this paper
• The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression

  2018cites this paper
• Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials

  2017cites this paper
• Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison

  2017cites this paper
• ADHD research in India: A narrative review.

  2017cites this paper
• Medical Comorbidities, Medications, and Sleep

  2017cites this paper
• Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder

  2017cites this paper
• Psychopharmacology of Neurodevelopmental Disorders in Children

  2016cites this paper
• An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments

  2016cites this paper
• Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis

  2016cites this paper
• Changes in behavior as side effects in methylphenidate treatment: review of the literature

  2016cites this paper
• Pediatric Psychopharmacology: Perspectives from Low Resource Countries

  2016cites this paper
• The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research

  2015influential citation
• Drug Class Review Pharmacol ogic Treatments for Attention Deficit Hyperactivity Disorder

  2015cites this paper
• Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry

  2015cites this paper
• Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?

  2015cites this paper
• Atomoxetine and Methylphenidate Treatment in ADHD

  2015cites this paper